Cargando…

Discovery of an antibody for pan-ebolavirus therapy

During the latest outbreak of Ebola virus disease in West Africa, monoclonal antibody therapy (e.g., ZMapp) was utilized to treat patients. However, due to the antigenic differences among the five ebolavirus species, the current therapeutic monoclonal antibodies are only effective against viruses of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furuyama, Wakako, Marzi, Andrea, Nanbo, Asuka, Haddock, Elaine, Maruyama, Junki, Miyamoto, Hiroko, Igarashi, Manabu, Yoshida, Reiko, Noyori, Osamu, Feldmann, Heinz, Takada, Ayato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748290/ https://www.ncbi.nlm.nih.gov/pubmed/26861827 http://dx.doi.org/10.1038/srep20514

Ejemplares similares

Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection
por: Furuyama, Wakako, et al.
Publicado: (2016)

A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection
por: Furuyama, Wakako, et al.
Publicado: (2020)

A polymorphism of the TIM-1 IgV domain: Implications for the susceptibility to filovirus infection
por: Kuroda, Makoto, et al.
Publicado: (2014)

Generation of bat-derived influenza viruses and their reassortants
por: Sato, Masahiro, et al.
Publicado: (2019)

Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor
por: Kondoh, Tatsunari, et al.
Publicado: (2017)

Characterization of the glycoproteins of bat-derived influenza viruses
por: Maruyama, Junki, et al.
Publicado: (2016)

Assembly and Budding of Ebolavirus
por: Noda, Takeshi, et al.
Publicado: (2006)

Genetic Predisposition To Acquire a Polybasic Cleavage Site for Highly Pathogenic Avian Influenza Virus Hemagglutinin
por: Nao, Naganori, et al.
Publicado: (2017)

Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
por: Marzi, Andrea, et al.
Publicado: (2012)

Detection of anti-ebolavirus antibodies in Ghanaian pigs
por: OGAWA, Hirohito, et al.
Publicado: (2022)

RNA Virus-Encoded miRNAs: Current Insights and Future Challenges
por: Nanbo, Asuka, et al.
Publicado: (2021)

A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades
por: Furuyama, Wakako, et al.
Publicado: (2020)

The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway
por: Furuyama, Wakako, et al.
Publicado: (2021)

Comparison of Antiviral Activity between IgA and IgG Specific to Influenza Virus Hemagglutinin: Increased Potential of IgA for Heterosubtypic Immunity
por: Muramatsu, Mieko, et al.
Publicado: (2014)

Development of an imaging system for visualization of Ebola virus glycoprotein throughout the viral lifecycle
por: Furuyama, Wakako, et al.
Publicado: (2022)

Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles
por: Nanbo, Asuka, et al.
Publicado: (2018)

Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
por: Bhatia, Bharti, et al.
Publicado: (2021)

A Single Amino Acid in the M1 Protein Responsible for the Different Pathogenic Potentials of H5N1 Highly Pathogenic Avian Influenza Virus Strains
por: Nao, Naganori, et al.
Publicado: (2015)

Heterosubtypic Antiviral Activity of Hemagglutinin-Specific Antibodies Induced by Intranasal Immunization with Inactivated Influenza Viruses in Mice
por: Muramatsu, Mieko, et al.
Publicado: (2013)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
por: Saito, Takeshi, et al.
Publicado: (2020)

Receptor-Mediated Host Cell Preference of a Bat-Derived Filovirus, Lloviu Virus
por: Takadate, Yoshihiro, et al.
Publicado: (2020)

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
por: Suder, Ellen, et al.
Publicado: (2018)

Ebolavirus in West Africa, and the use of experimental therapies or vaccines
por: Hoenen, Thomas, et al.
Publicado: (2014)

Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
por: Gilchuk, Pavlo, et al.
Publicado: (2018)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
por: Kuang, Erin, et al.
Publicado: (2022)

Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner
por: Nanbo, Asuka, et al.
Publicado: (2010)

Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain
por: Kasajima, Nodoka, et al.
Publicado: (2021)

Single Nucleotide Variants of the Human TIM-1 IgV Domain with Reduced Ability to Promote Viral Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Predicting the Antigenic Structure of the Pandemic (H1N1) 2009 Influenza Virus Hemagglutinin
por: Igarashi, Manabu, et al.
Publicado: (2010)

Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development
por: Murin, Charles D., et al.
Publicado: (2022)

Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection
por: Furuyama, Wakako, et al.
Publicado: (2020)

A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity
por: Fujihira, Haruhiko, et al.
Publicado: (2018)

Interferon-Induced Transmembrane Protein–Mediated Inhibition of Host Cell Entry of Ebolaviruses
por: Wrensch, Florian, et al.
Publicado: (2015)

Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection
por: Okuya, Kosuke, et al.
Publicado: (2022)

Macrophage infection, activation, and histopathological findings in ebolavirus infection
por: Wanninger, Timothy G., et al.
Publicado: (2022)

A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus
por: Bhatia, Bharti, et al.
Publicado: (2021)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses
por: Yoshida, Reiko, et al.
Publicado: (2009)

Influenza A Virus M2 Protein: Roles from Ingress to Egress
por: Manzoor, Rashid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o1fc4afm5f71cakg03chtioh0r